Predictive Technology Group Inc (PRED)

[stockguru1971]

There are multiple tests in the market, what makes pred unique is the endometriosis component which is protected under patent. Endo is a huge problem in its own right so it’s obvious that any women looking for a fertility overview would want to cover this and use the test.

Re cost, I believe it’s north of $1500 per test which in the land of fertility is a tiny cost. Margins are incredible I believe and as you can imagine won’t be discussed with us!

What people don’t get is that the numbers Thomas eluded to are for the US market . The worlds a big place! Same medical issues everywhere.

Also this is just on art guide , what about fertility DX which offers a first in class genetic mapping for the family.

As I’ve always said, this is not a stem cell company and you are now seeing a pivot towards where the true future of the company is.

Re the QX debate, it makes perfect sense, it’s a forward step towards nasdaq,

QX would not be the destination but part of the journey to nasdaq. If they do go down that route, then I believe it’s smart and a great step